Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Early Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Early Phase 1
1 (100.0%)Spread of PrabotulinumtoxinA-xvfs Versus OnabotulinumtoxinA in the Treatment of Forehead Rhytides
Early Phase 1
Completed
- Conditions
- Rhytides
- Interventions
- Drug: PrabotulinumtoxinA-Xvfs
- First Posted Date
- 2023-04-11
- Last Posted Date
- 2024-03-13
- Target Recruit Count
- 10
- Registration Number
- NCT05807412
- Locations
- 🇺🇸
Lupo Center for Aesthetic and General Dermatology, New Orleans, Louisiana, United States
News
No news found